Ultrasound-assisted treatment for anal pain in cancer patients
Efficacy of Ultrasound-assisted Caudal Epidural Pulsed Radiofrequency for Anal and Perineal Pain in Cancer Patients, a Prospective Randomized Clinical Study
This study is testing whether a new ultrasound treatment can help cancer patients with anal and perineal pain feel better and reduce their need for pain medication.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Asyut) |
| Trial ID | NCT06008899 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of ultrasound-assisted caudal epidural pulsed radiofrequency (PRF) in alleviating anal and perineal pain in cancer patients. Participants will be assessed using visual analog scale (VAS) scores at baseline and at two, four, and eight weeks post-treatment. Secondary outcomes will include the impact on opioid usage, quality of life, patient satisfaction, and any side effects related to the intervention. The goal is to provide a non-invasive pain management option for patients suffering from cancer-related pain.
Who should consider this trial
Good fit: Ideal candidates are cancer patients experiencing anal or perineal pain with an ASA physical status of I or III.
Not a fit: Patients with coagulopathies, significant cardiac or respiratory diseases, or allergies to contrast dye may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and improve the quality of life for cancer patients experiencing anal pain.
How similar studies have performed: While this approach is innovative, similar studies using pulsed radiofrequency for pain management have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * American Society of Anesthesiology physical status of I or III (ASA), of both sex * cancer-related anal or perineal pain Exclusion Criteria: * coagulopathies * allergies to the contrast dye * patients with moderate or significant cardiac/respiratory disease or hepatic
Where this trial is running
Asyut
- South Egypt Cancer instIitute — Asyut, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.